Related by context. Frequent words. (Click for all words.) 72 lymphoma CTCL 70 relapsed refractory multiple myeloma 69 Amrubicin 68 cutaneous T cell 68 metastatic renal cell carcinoma 68 refractory Hodgkin lymphoma 68 refractory multiple myeloma 68 mRCC 67 axitinib 66 tanespimycin 65 liposomal formulation 65 relapsed refractory 65 heavily pretreated 65 Acute Myeloid Leukemia AML 65 B CLL 65 phase IIb clinical 65 acute myelogenous leukemia AML 65 Cloretazine R VNP#M 65 chronic lymphocytic leukemia CLL 64 gastrointestinal stromal tumors 64 relapsed multiple myeloma 64 advanced carcinoid 64 metastatic hormone refractory 64 phase IIa 64 RRMS patients 64 OncoVEX GM CSF 64 KRN# 64 Vandetanib 64 myelodysplastic syndrome MDS 63 HGS ETR1 63 vandetanib 63 lupus nephritis 63 Jevtana 63 refractory peripheral T 63 pheochromocytoma 63 malignant pleural mesothelioma 63 Alemtuzumab 63 Irinotecan 63 Azedra 63 HER2 positive metastatic breast 63 Reolysin 63 ALN TTR# 63 Torisel 63 temsirolimus 63 superficial bladder cancer 63 secondary hyperparathyroidism 63 Pirfenidone 63 myelodysplastic syndromes MDS 63 Pivotal Phase III 63 Voreloxin 63 R sorafenib tablets 62 Orphan Drug status 62 myeloproliferative disorders 62 Lenalidomide 62 chronic myeloid leukemia CML 62 androgen independent 62 unresectable 62 NEUMUNE 62 Phenoptin 62 anticancer compound 62 Acute Myeloid Leukemia 62 cell chronic lymphocytic 62 Everolimus 62 pertuzumab 62 intravenously administered 62 ISTODAX 62 biologic therapy 62 registrational trial 62 Natalizumab 62 Epratuzumab 62 APOPTONE 62 paroxysmal nocturnal hemoglobinuria PNH 62 sapacitabine 62 pancreatic insufficiency 62 IV melanoma 62 castration resistant prostate cancer 62 Phase Ib clinical 62 glioblastoma multiforme GBM 62 medullary thyroid cancer 62 romidepsin 61 anticancer therapy 61 dirucotide 61 azacitidine 61 AA amyloidosis 61 neoadjuvant 61 mTOR inhibitor 61 calcineurin inhibitors 61 indolent NHL 61 Panzem R 61 acute myeloid leukemia AML 61 TORISEL 61 Fludara 61 luteinizing hormone releasing 61 ZYBRESTAT 61 orally bioavailable 61 diabetic neuropathic pain 61 myelofibrosis 61 refractory PTCL 61 imatinib mesylate 61 elotuzumab 61 TELCYTA